Stay updated with breaking news from Track Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 177,906 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $23.89, for a total transaction of $4,250,174.34. Following the completion of the transaction, the director now owns 7,148,211 shares in […]
COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) Director Ekaterina Malievskaia sold 19,853 shares of the business’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $10.59, for a total value of $210,243.27. Following the completion of the sale, the director now directly owns 4,144,994 shares in […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $95.00 and last traded at $94.95, with a volume of 237699 shares traded. The stock had previously closed at $91.50. Analyst Upgrades and Downgrades Several research firms recently […]
Virtus ETF Advisers LLC decreased its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 9.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 7,831 shares of the biopharmaceutical company’s stock after selling 785 shares during the period. Virtus ETF Advisers LLC’s holdings in […]
Forefront Analytics LLC bought a new stake in Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,183 shares of the company’s stock, valued at approximately $110,000. Forefront Analytics LLC owned 0.06% […]